DSM-Firmenich

DSM-Firmenich AG is a Swiss-Dutch multinational ingredients and specialty-chemicals company created through the combination of Royal DSM of the Netherlands and Firmenich of Switzerland. The merger was completed on 9 May 2023 after the two companies presented the transaction as a merger of equals intended to create a major global supplier to the nutrition, health, beauty, food, beverage, and fragrance industries. The resulting company combines DSM's long-standing activities in nutrition, health, bioscience, vitamins, food ingredients, and animal-nutrition solutions with Firmenich's expertise in perfumery, fragrance compounds, flavor creation, and ingredients for personal care and consumer products. The company operates internationally through more than 300 locations in over sixty countries. Its activities are organized into three broad business units: Perfumery & Beauty; Health, Nutrition, and Care; and Taste, Texture & Health. These units serve consumer-facing and industrial customers, including manufacturers of foods, beverages, dietary supplements, cosmetics, personal-care products, fragrances, and other formulated goods. The business is therefore primarily a business-to-business supplier: consumers usually encounter DSM-Firmenich through the branded or unbranded ingredients incorporated into products made by other companies. DSM-Firmenich's competitive proposition rests on the combination of scientific research, formulation expertise, sensory design, biotechnology, and global production and customer-support capabilities. In flavors and fragrances, the company develops taste and scent systems for food, beverage, fine-fragrance, personal-care, and household applications. In nutrition and health, it supplies vitamins, nutritional ingredients, supplements, and other functional components. Its broader portfolio also includes ingredients and technologies intended to improve taste, texture, stability, nutritional value, and consumer appeal. The company has a cross-border corporate identity. It is associated with Switzerland through Firmenich and its corporate heritage, while its DSM heritage is Dutch and the company has a major headquarters presence in Maastricht, Netherlands. A new Maastricht headquarters was officially opened on 30 May 2024 by Queen Máxima of the Netherlands. DSM-Firmenich is listed on Euronext Amsterdam and is a constituent of the AEX index. Its formation represents a strategic shift toward a broad, integrated ingredients platform rather than a conventional commodity-chemicals model, with emphasis on higher-value specialty ingredients, innovation, and applications expertise. The post-merger portfolio has also been subject to strategic reshaping. In February 2025, Novonesis agreed to acquire DSM-Firmenich's shares in the Feed Enzyme Alliance for €1.5 billion. The arrangement was intended to dissolve the alliance and transfer sales and distribution activities to Novonesis. This transaction illustrates the company's effort to refine its portfolio while concentrating on areas where its nutrition, health, taste, fragrance, and beauty capabilities are most complementary.

DSM-Firmenich emerged from the combination of two established European businesses with different but complementary histories. Royal DSM developed from a Dutch industrial and chemical heritage and subsequently built substantial activities in nutrition, health, bioscience, food ingredients, vitamins, and animal nutrition. Firmenich, founded in Switzerland, became internationally known for fragrance creation, perfumery, flavors, and related ingredients supplied to consumer-goods manufacturers. Their combination brought together DSM's science and nutrition platform with Firmenich's sensory, fragrance, and beauty capabilities. The merger was first announced in 2022. Both organizations described the proposed transaction as a merger of equals, with the stated objective of establishing a leading company in nutrition and personal-care ingredients. Rather than simply adding a fragrance business to a chemical group, the transaction was designed to create a broader ingredients company serving several connected markets: food and beverages, dietary supplements, health products, cosmetics, personal care, fine fragrance, and household applications. The combination was completed on 9 May 2023, when DSM-Firmenich began operating as the successor group to the two businesses. After completion, the company organized its activities into three principal business units: Perfumery & Beauty; Health, Nutrition, and Care; and Taste, Texture & Health. This structure reflects the company's integrated approach to formulation and consumer experience. Perfumery & Beauty covers fragrance creation, perfumery materials, and ingredients used in beauty and personal-care products. Health, Nutrition, and Care includes vitamins, nutritional ingredients, supplements, and related health applications. Taste, Texture & Health brings together flavor, food, beverage, texture, and functional-ingredient capabilities. The post-merger group has an extensive international operating footprint, with more than 300 locations in over sixty countries. Its customers are mainly manufacturers and brand owners that use DSM-Firmenich ingredients and formulation systems in finished consumer products. The company's role can range from supplying a single ingredient to developing a complete taste, fragrance, nutritional, or sensory solution tailored to a customer's product and market requirements. A visible milestone in the company's early post-merger period came on 30 May 2024, when a new headquarters in Maastricht was officially opened by Queen Máxima of the Netherlands. The Maastricht site underscores the company's Dutch and Swiss heritage and its cross-border corporate identity. DSM-Firmenich is listed on Euronext Amsterdam and forms part of the AEX index. The company has also pursued portfolio changes after the merger. On 11 February 2025, Novonesis reached an agreement to acquire DSM-Firmenich's shares in the Feed Enzyme Alliance for €1.5 billion. Under the agreement, the alliance would be dissolved and Novonesis would assume its sales and distribution activities. The transaction represents a move to simplify or refocus the portfolio while retaining the company's broader presence in nutrition, health, taste, fragrance, beauty, and care markets. DSM-Firmenich's present identity is consequently that of a global business-to-business ingredients group rather than a consumer brand in the conventional sense. Its products are often embedded in foods, beverages, supplements, fragrances, cosmetics, and personal-care goods sold under other companies' brands. Its strategic rationale depends on combining research, biotechnology, formulation, sensory science, application development, and international customer relationships across these markets.

1. 2025Feed Enzyme Alliance transaction agreed with Novonesis

   Novonesis agreed to acquire DSM-Firmenich's shares in the Feed Enzyme Alliance for €1.5 billion, with the alliance to be dissolved and its sales and distribution activities transferred.

   Source
2. 2024Maastricht headquarters officially opened

   A new headquarters in Maastricht was opened on 30 May 2024 in an event attended by Queen Máxima of the Netherlands.

   Source
3. 2023DSM-Firmenich merger completed

   The combination of Royal DSM and Firmenich was completed on 9 May 2023, establishing DSM-Firmenich AG.

   Source
4. 2022DSM and Firmenich announce proposed merger

   The two companies announced plans to combine in a transaction presented as a merger of equals aimed at creating a major nutrition and personal-care ingredients group.

   Source

A science-led, innovation-oriented, and globally integrated supplier of specialty ingredients and solutions for nutrition, health, taste, texture, fragrance, beauty, and personal care, with an emphasis on premium applications and sustainability.

• Perfumery and fragrance solutionsFragrance and perfumery

  DSM-Firmenich develops fragrance compositions and perfumery ingredients for fine fragrance, personal care, beauty, household, and other consumer applications. The offering combines creative scent development with ingredient science, formulation support, and application expertise. Products are generally supplied to manufacturers and brand owners rather than sold directly to consumers under the DSM-Firmenich name.

• Flavors and taste systemsFood and beverage ingredients

  The company's taste activities provide flavor systems and related solutions for food and beverage manufacturers. These solutions can support sensory profiles, product differentiation, reformulation, and consumer acceptance. The business sits within the broader Taste, Texture & Health unit and is connected with expertise in food formulation and functional ingredients.

• Nutrition and dietary-supplement ingredientsNutrition and health

  DSM-Firmenich supplies vitamins, nutritional ingredients, and components used in dietary supplements and health-oriented products. These ingredients draw on the DSM heritage in nutrition and health and are supplied to manufacturers developing products for human nutrition, wellness, and related applications.

• Beauty and personal-care ingredientsBeauty and personal care

  Beauty and personal-care ingredients combine Firmenich's fragrance and sensory capabilities with DSM-Firmenich's broader formulation and ingredient expertise. Applications include cosmetics, skin care, hair care, and other personal-care products. The products are designed for incorporation into finished goods made by consumer-products companies.

• Taste, texture, and health solutionsFood technology

  This solution area brings together taste, texture, and functional-health capabilities for food and beverage applications. It addresses the interaction between sensory quality and nutritional or functional objectives, helping manufacturers develop products that meet consumer expectations while modifying ingredients, formulations, or nutritional profiles.

• 2025Transfer Feed Enzyme Alliance activities to NovonesisM&A

  Novonesis and DSM-Firmenich agreed to change ownership and commercial responsibility for the Feed Enzyme Alliance.

  What changed. Novonesis agreed to acquire DSM-Firmenich's shares in the alliance for €1.5 billion. The alliance would be dissolved and Novonesis would take over sales and distribution activities.

  Aftermath. The agreement would remove the alliance from DSM-Firmenich's portfolio and place its commercial activities under Novonesis.

  Transaction value. €1.5 billion (Agreement announced 11 February 2025)

  Source
• 2022Pursue a merger of equals with FirmenichM&A

  DSM and Firmenich sought to create a global nutrition, health, fragrance, beauty, and personal-care ingredients company by combining complementary portfolios and capabilities.

  What changed. The companies announced the proposed combination and completed the merger on 9 May 2023.

  Aftermath. The transaction created DSM-Firmenich, a listed multinational with three principal business units covering Perfumery & Beauty, Health, Nutrition, and Care, and Taste, Texture & Health.

  Source

• 2025Novonesis agrees to acquire DSM-Firmenich stake in Feed Enzyme Alliance

  Novonesis reached an agreement to acquire DSM-Firmenich's shares in the Feed Enzyme Alliance for €1.5 billion. The agreement would dissolve the alliance and transfer sales and distribution activities to Novonesis.

  M&A
  Source
• 2024DSM-Firmenich opens new Maastricht headquarters

  A new headquarters in Maastricht, Netherlands, was officially opened on 30 May 2024 by Queen Máxima of the Netherlands.

  Other
  Source
• 2023DSM and Firmenich complete merger

  The Dutch Royal DSM and Swiss Firmenich completed their combination on 9 May 2023, creating DSM-Firmenich as a global ingredients company.

  M&A
  Source

1. DSM-Firmenich
2. DSM-Firmenich official website